Inhibitor of RNA polymerase I shows promise as potential treatment for acute myeloid leukemia and multiple myeloma
The investigational drug CX-5461, which blocks the protein RNA polymerase I (Pol I), prolonged survival in mouse models of highly aggressive acute myeloid leukemia (AML) and multiple myeloma, according to data presented at ...
Sep 23, 2014
0
0